PAS
IDYA icon

Park Avenue Securities’s IDEAYA Biosciences IDYA Stock Holding History

Park Avenue Securities’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Sell
6,481
-241
-4% -$7.38K ﹤0.01% 1634
2026
Q1 		$224K Sell
6,722
-1,492
-18% -$50.1K ﹤0.01% 1431
2025
Q4 		$284K Sell
8,214
-94
-1% -$3K ﹤0.01% 1336
2025
Q3 		$226K Buy
+8,308
New +$201K ﹤0.01% 1522

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Park Avenue Securities's IDYA Position: Q2 2026 in Review

Park Avenue Securities reduced its IDEAYA Biosciences (IDYA) stake by 3.6% in Q2 2026, selling an estimated $7.38K and leaving 6,481 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #1634.

Park Avenue Securities first reported a position in IDYA in Q3 2025 and has held it in 4 quarters since. The position peaked at $284K in Q4 2025. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Park Avenue Securities held 6,481 shares of IDEAYA Biosciences worth $242K as of Q2 2026.
  • Park Avenue Securities sold 241 IDEAYA Biosciences shares in Q2 2026, an estimated $7.38K.
  • IDEAYA Biosciences made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1634 holding.
  • Park Avenue Securities first reported a position in IDEAYA Biosciences in Q3 2025 and has held it in 4 quarters since.
  • Park Avenue Securities's IDEAYA Biosciences position peaked at $284K in Q4 2025.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.